Summary for Tradename: OMNISCAN
Clinical Trials for: OMNISCAN
Post-marketing Safety Study in Patients With Moderate Renal Insufficiency Who Receive Omniscan for Contrast-enhanced Magnetic Resonance Imaging (MRI)
Status: Completed Condition: Chronic Kidney Disease; Renal Insufficiency
A Study of Gadodiamide Injection in Myocardial Perfusion Magnetic Resonance Imaging
Status: Completed Condition: Coronary Artery Disease
A Safety & Efficacy Clinical Study to Evaluate the Narrowing of the Renal Arteries While Using Gadodiamide
Status: Completed Condition: Renal Artery Stenosis
A Safety and Efficacy Clinical Study to Evaluate the Narrowing of the Aorto-Iliac Arteries While Using Gadodiamide
Status: Completed Condition: Aorto-Iliac Stenosis; Arterial Occlusive Diseases
A Study Comparing Two Magnetic Resonance Imaging (MRI) Contrast Agents in MRI of the Brain
Status: Completed Condition: Brain Pathology
Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities
Status: Terminated Condition: Glioblastoma Multiforme
Comparative Study of Non-enhanced Versus Contrast Enhanced MR Angiography in Peripheral Arterial Disease on a 3T MR Scanner.
Status: Completed Condition: Peripheral Arterial Disease
Neurovascular Non Contrast-Enhanced MR Angiography at 3T
Status: Recruiting Condition: Neurovascular Diseases
Efficacy and Safety of Primovist in Chinese Patients
Status: Completed Condition: Known or Suspected Focal Liver Lesions
Courtesy of ClinicalTrials.org
See more clinical trials for this drug
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|INJECTABLE;INJECTION||020123||Jan 8, 1993||RX||Yes||5,560,903||<disabled>||Y||<disabled>|
|INJECTABLE;INJECTION||022066||Sep 5, 2007||DISCN||No||5,560,903||<disabled>||Y||<disabled>|
|INJECTABLE;INJECTION||022066||Sep 5, 2007||RX||Yes||5,560,903||<disabled>||Y||<disabled>|
|This preview shows a limited data set|
Complete access is available with a Subscription
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639